| Sources | Names Used |
|---|---|
| GDSC1000 | THZ-2-102-1 |
| PharmacoGx | THZ-2-102-1 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RABGGTB | GDSC1000 | pan-cancer | AAC | 0.093 | 0.001 |
| mRNA | SLC39A11 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | ARX | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | PDE5A | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | GADL1 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | ZNF771 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | RBM47 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | TANC1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | SH3BP4 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | C2CD5 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
